Sort by
Refine Your Search
-
modalities to the diseased site in the small intestine. GENEGUT will tackle this delivery dilemma by utilising novel biomaterials to formulate RNA nanoparticles (NPs). The efficacy and mechanisms targeted by
Enter an email to receive alerts for nanoparticle "https:" positions